Abstract
BACKGROUND Malaria still remains a major public health problem globally including in Indonesia. Currently, most of malaria cases are in the eastern part of the country. However, there is no information yet regarding the trends of malaria prevalence at rural health institution particularly at Mangili Public Health Centre.
AIM This study aims to explore the trend of malaria prevalence over a ten-year period.
METHODS A retrospective study was carried out in the Centre. The laboratory record books from January 2013 to December 2022 were carefully reviewed to identify malaria cases based on the sex, age, type of plasmodium, year and month when the patients diagnosed malaria microscopically. The trend analysis was applied to identify the trend of malaria over the period under review.
RESULTS Over the last ten years, 19,938 blood films were requested for malaria diagnosis at the health centre. From this number, 3.679 (18.5%, with 95% confidence interval (CI): 17.2 – 19.7) were microscopically confirmed malaria cases. From the total cases, prevalence of plasmodium falciparum, vivax and mix infection was 85.5% with 95% CI: 84.3 – 86.8; 6.39% with 95% CI: 3.26 – 9.51; and 7.58% with 95% CI: 4.48 – 10.7 respectively. The number of malaria cases reached a peak in January, whilst it was the lowest in October. Overall trend on the prevalence of malaria decreased significantly, however the prevalence of plasmodium falciparum increased considerably during COVI-19 pandemic. The prevalence of plasmodium falciparum, vivax and mixed infection was higher in male, age group ≥ 15, and student than their counterpart.
CONCLUSION Malaria remains high in this area with plasmodium falciparum is the dominant species followed by mixed infection. Scaling up malaria control and prevention activities are very crucial to significantly reduce the burden of malaria and to boost malaria elimination in this region.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research and Community Service Centre of Nusa Cendana University Kupang NTT Indonesia.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by Health Research Ethics Committee of Nusa Cendana University (reference number 51/UN15.16/KEPK/2023)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding This research was supported by Research and Community Service Centre of Nusa Cendana University Kupang NTT Indonesia.
Email: robertus_guntur{at}staf.undana.ac.id; Phone: +6281325525489;
Email: kusumaningrumdamai{at}yahoo.com; Phone +6282136298416
Email: yulianti.bria{at}unwira.ac.id; Phone: +6281236289919
Data Availability
All data produced in the present work are contained in the manuscript
